Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2023-10-09 Regulatory Filings
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-10-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the closure of the trading window due to insider trading regulations ahead of the financial results announcement for the quarter and half year ending September 30, 2023. It does not contain any financial data, results, or detailed report content. It is an announcement related to compliance and trading restrictions, not a financial report or earnings release. The document length is only 1172 characters, indicating it is a brief regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related notification rather than a financial report or earnings release.
2023-09-28 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report dated September 15, 2023, addressed to stock exchanges regarding the 4th Annual General Meeting (AGM) of Aarti Pharmalabs Limited held on September 14, 2023. It includes a Scrutinizer's Report pursuant to Section 108 of the Companies Act, 2013, and voting results pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report details the e-voting process, vote counts for various resolutions including adoption of financial statements, appointment of directors, appointment of auditors, remuneration approval, and stock option approval. The document is not the AGM presentation itself but the official voting results and scrutinizer's report following the AGM. This matches the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, not just an announcement of a report, so it is not RPA or RNS. Therefore, the correct classification is DVA with high confidence.
2023-09-15 English
Investor Presentation
AGM Information Classification · 95% confidence The document is a presentation made to shareholders at the 4th Annual General Meeting (AGM) held on September 14, 2023. It is addressed to stock exchanges under Regulation 30 of SEBI (LODR) Regulations 2015, which mandates disclosure of material events including presentations. The content includes company overview, financial performance, and key metrics, typical of an investor or shareholder presentation at an AGM. The document is not the full annual report but a presentation shared during the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is the presentation itself, not just an announcement of a report publication.
2023-09-14 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of the 4th Annual General Meeting of Aarti Pharmalabs Limited' and details the events of the AGM held on September 14, 2023. It includes information about attendance, the agenda items discussed (such as adoption of financial statements, appointment of directors and auditors, approval of remuneration, and stock option plan), shareholder questions, and voting procedures. The document is a summary of the meeting proceedings rather than the full annual report or financial statements. It also references the Annual Report for the financial year ended March 31, 2023, but does not contain the report itself. The document length is 6944 characters, which is consistent with a detailed meeting summary. Therefore, this document fits the category of AGM Information (AGM-R).
2023-09-14 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of newspaper advertisements. These advertisements announce the completion of electronic dispatch of the Annual Report for the financial year 2022-23 and the Notice of the 4th Annual General Meeting (AGM). The letter references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 30 and 47, which pertain to disclosures and advertisements. The document does not contain the Annual Report itself but rather informs about the dispatch and publication of advertisements related to the Annual Report and AGM notice. The document length is short (1930 characters), and it primarily serves as an announcement rather than the report itself. According to the "Menu vs Meal" rule, this is a report publication announcement rather than the Annual Report or AGM materials themselves.
2023-08-23 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.